Seattle, Washington--(Newsfile Corp. - November 8, 2017) - CFN Media Group ("CannabisFN"), the leading creative agency and media
network dedicated to legal cannabis, announces publication of an article covering the innovative product lines offered by
The Hydropothecary Corporation (TSXV: THCX), focusing on the Decarb product
line comprised of fine milled, activated medical marijuana powders.
Canada's cannabis industry is expected to reach $22.6 billion in size over the coming years, according to Deloitte, driven by
the legalization of recreational marijuana next year. While the number of licensed producers has grown, the pace of licenses to
extract, produce, and sell cannabis oil has lagged behind. This is concerning since the cannabis oil sector grew more than 871%
between April 2016 and March 2017, according to Health Canada.
The Hydropothecary Corporation has one of about 20 licenses to produce and sell cannabis oils, but it's also focused on
developing other non-flower products to address different patient populations. With many patients reluctant to smoke marijuana and
many doctors looking for better options, the company believes that there's a much larger market for non-flower products that
remains substantially untapped.
Taking A New Approach
Hydropothecary recently launched Decarb Micro THC and Decarb Micro CBD as ready-to-consume, activated medical marijuana powders.
These products provide a much-needed alternative to smoking, vaping, and cannabis oils, while enabling consumers to adjust their
consumption of medical cannabis through the intake of minimal amounts of THC or CBD. They can also be periodically used to maintain
cannabinoid levels throughout the day. The two new Micro products add variety to the company's existing line of four Decarb products.
"This new release is the latest example of Hydropothecary's ongoing commitment to product innovation and our focus on customer
needs," said Hydropothecary CEO Sebastien St-Louis in a recent press release. "Decarb Micro THC and Decarb Micro CBD ensure our
clients have flexibility together with affordable, discreet, and easy-to-understand products."
At just $3 per gram, the new Decarb products are among the lowest priced premium cannabis products on the market and are much
more cost-effective to produce than cannabis oils. An added benefit is that they aren't subject to the same restrictions as
cannabis oils, which makes them easier to market and sell throughout Canada. These benefits could translate to higher revenue and
profitability over the long-term as the product gains traction.
Hydropothecary's Unique Niche
Hydropothecary is one of only two licensed producers of medical cannabis under Health Canada's ACMPR program located in Quebec.
Provincial cultivation restrictions, that are beginning to appear in other provinces, could create a barrier to entry for other
licensed producers located elsewhere. Many Quebecois are also drawn to local companies rather than national brands, which could
increase the company's appeal in the populous province.
With 20 medical marijuana products priced at $3 to $15 per gram, the company serves a wide range of patient populations, from
mass-market consumers to discerning premium customers. The company's products are sun grown and rigorously tested for quality and
purity to ensure that there are no recalls, which have had an adverse effect on many companies across Canada since the drug was
legalized.
Hydropothecary operates with some of the lowest hydro costs in the market — especially compared to Ontario. This helps the
company keep its costs extremely low relative to other licensed producers. At the same time, the company has initiated a dramatic
production area expansion to 300,000 square feet, which could enable 25,000 kilograms per year of product. The goal is to leverage
increased economies of scale to lower its marginal costs even more.
The company is also firmly committed to ongoing research and development to maintain their lead in the market. In addition to
the Decarb product lines, the company's Elixir No. 1 was the country's first legal sublingual cannabis oil mist launched in July
2017. The company's ongoing innovation should help maintain a barrier to entry, while preserving relatively high profit margins as
cannabis flower becomes increasingly commoditized.
The Bottom Line
The Hydropothecary Corporation (TSXV: THCX) is uniquely positioned for success in Canada's burgeoning cannabis industry. With
innovative new products and a unique location, the company differentiates itself from many other companies in the space focused
solely on scaling up grow operations.
Please follow the link to read the full article: http://www.cannabisfn.com/hydropothecarys-decarb-change-way-cannabis-consumed/
About CFN Media
CFN Media (CannabisFN) is the leading creative agency and media network dedicated to legal cannabis. We help marijuana
businesses attract investors, customers (B2B, B2C), capital, and media visibility. Private and public marijuana companies and
brands in the US and Canada rely on CFN Media to grow and succeed.
Learn how to become a CFN Media client company, brand or entrepreneur: http://www.cannabisfn.com/become-featured-company/
Download the CFN Media iOS mobile app to access the world of cannabis from the palm of your hand: https://itunes.apple.com/us/app/cannabisfn/id988009247?ls=1&mt=8
Or visit our homepage and enter your mobile number under the Apple App Store logo to receive a download link text on your
iPhone: http://www.cannabisfn.com
Disclaimer:
Except for the historical information presented herein, matters discussed in this release contain forward-looking statements
that are subject to certain risks and uncertainties that could cause actual results to differ materially from any future results,
performance or achievements expressed or implied by such statements. Emerging Growth LLC, which owns CFN Media and CannabisFN.com,
is not registered with any financial or securities regulatory authority, and does not provide nor claims to provide investment
advice or recommendations to readers of this release. Emerging Growth LLC may from time to time have a position in the securities
mentioned herein and may increase or decrease such positions without notice. For making specific investment decisions, readers
should seek their own advice. Emerging Growth LLC may be compensated for its services in the form of cash-based compensation or
equity securities in the companies it writes about, or a combination of the two. For full disclosure please visit: http://www.cannabisfn.com/legal-disclaimer/.
CFN Media
Frank Lane
206-369-7050
flane@cannabisfn.com
